title: Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain.
abstract: Prenatal exposure to infection appears to increase the risk of schizophrenia and other neurodevelopmental disorders. We have hypothesized that cytokines, generated in response to maternal infection, play a key mechanistic role in this association. E16 timed pregnancy rats were injected i.p. with Escherichia coli lipopolysaccharide (LPS) to model prenatal exposure to infection. Placenta, amniotic fluid and fetal brains were collected 2 and 8h after LPS exposure. There was a significant treatment effect of low-dose (0.5mg/kg) LPS on placenta cytokine levels, with significant increases of interleukin (IL)-1beta (P<0.0001), IL-6 (P<0.0001), and tumor necrosis factor-alpha (TNF-alpha) (P=0.0001) over the 2 and 8h time course. In amniotic fluid, there was a significant effect of treatment on IL-6 levels (P=0.0006). Two hours after maternal administration of high-dose (2.5mg/kg) LPS, there were significant elevations of placenta IL-6 (P<0.0001), TNF-alpha (P<0.0001), a significant increase of TNF-alpha in amniotic fluid (P=0.008), and a small but significant decrease in TNF-alpha (P=0.035) in fetal brain. Maternal exposure to infection alters pro-inflammatory cytokine levels in the fetal environment, which may have a significant impact on the developing brain.
authors.affiliation: Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7160, USA.
authors.forename: A
authors.initials: A
authors.lastname: Urakubo
authors.forename: L F
authors.initials: LF
authors.lastname: Jarskog
authors.forename: J A
authors.initials: JA
authors.lastname: Lieberman
authors.forename: J H
authors.initials: JH
authors.lastname: Gilmore
mesh_terms: D000653:Amniotic Fluid / Q000276:immunology*; D000818:Animals; D001921:Brain / Q000196:embryology / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D004926:Escherichia coli / Q000276:immunology; D005260:Female; D005333:Fetus / Q000276:immunology*; D008070:Lipopolysaccharides / Q000276:immunology; D008431:Maternal-Fetal Exchange / Q000276:immunology; D010920:Placenta / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology*; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D016207:Cytokines; D008070:Lipopolysaccharides